1. Home
  2. CNSP vs IDAI Comparison

CNSP vs IDAI Comparison

Compare CNSP & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNSP
  • IDAI
  • Stock Information
  • Founded
  • CNSP 2017
  • IDAI 2016
  • Country
  • CNSP United States
  • IDAI United States
  • Employees
  • CNSP N/A
  • IDAI N/A
  • Industry
  • CNSP Biotechnology: Pharmaceutical Preparations
  • IDAI Computer Software: Prepackaged Software
  • Sector
  • CNSP Health Care
  • IDAI Technology
  • Exchange
  • CNSP Nasdaq
  • IDAI Nasdaq
  • Market Cap
  • CNSP 5.6M
  • IDAI 5.5M
  • IPO Year
  • CNSP 2019
  • IDAI N/A
  • Fundamental
  • Price
  • CNSP $1.04
  • IDAI $1.99
  • Analyst Decision
  • CNSP Hold
  • IDAI
  • Analyst Count
  • CNSP 1
  • IDAI 0
  • Target Price
  • CNSP N/A
  • IDAI N/A
  • AVG Volume (30 Days)
  • CNSP 224.0K
  • IDAI 85.8K
  • Earning Date
  • CNSP 05-14-2025
  • IDAI 05-13-2025
  • Dividend Yield
  • CNSP N/A
  • IDAI N/A
  • EPS Growth
  • CNSP N/A
  • IDAI N/A
  • EPS
  • CNSP N/A
  • IDAI N/A
  • Revenue
  • CNSP N/A
  • IDAI $3,082,348.00
  • Revenue This Year
  • CNSP N/A
  • IDAI $65.46
  • Revenue Next Year
  • CNSP N/A
  • IDAI N/A
  • P/E Ratio
  • CNSP N/A
  • IDAI N/A
  • Revenue Growth
  • CNSP N/A
  • IDAI N/A
  • 52 Week Low
  • CNSP $0.77
  • IDAI $0.15
  • 52 Week High
  • CNSP $800.00
  • IDAI $8.96
  • Technical
  • Relative Strength Index (RSI)
  • CNSP 36.68
  • IDAI 55.69
  • Support Level
  • CNSP $0.83
  • IDAI $1.43
  • Resistance Level
  • CNSP $1.37
  • IDAI $1.77
  • Average True Range (ATR)
  • CNSP 0.15
  • IDAI 0.19
  • MACD
  • CNSP 0.07
  • IDAI 0.06
  • Stochastic Oscillator
  • CNSP 44.82
  • IDAI 100.00

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

About IDAI T Stamp Inc.

T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility.

Share on Social Networks: